Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003119290 | SCV003790610 | pathogenic | Ehlers-Danlos syndrome, type 4 | 2022-10-07 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the COL3A1 gene has been identified. Loss-of-function variants in COL3A1 are known to be pathogenic (PMID: 24922459). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. Isolated whole-gene deletions of COL3A1 have not been reported in the literature. However, larger copy number events that include this gene have been reported (PMID: 20648054). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV003109227 | SCV003793177 | pathogenic | Ehlers-Danlos syndrome, classic type, 1 | 2022-10-07 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the COL5A2 gene has been identified. Loss-of-function variants in COL5A2 are known to be pathogenic (PMID: 23587214). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. Isolated whole-gene deletions of COL5A2 have not been reported in the literature. However, larger copy number events that include this gene have been reported (PMID: 20648054). For these reasons, this variant has been classified as Pathogenic. |